CAS 1429054-28-3

IDF-11774

CAS : 1429054-28-3

Formule : C₂₃H₃₂N₂O₂

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 368.5124

Ref: IN-DA01EOG7

1-(4-Methyl-1-Piperazinyl)-2-(4-Tricyclo[3.3.1.13,7]Dec-1-Ylphenoxy)-Ethanone

CAS : 1429054-28-3

1-(4-Methyl-1-Piperazinyl)-2-(4-Tricyclo[3.3.1.13,7]Dec-1-Ylphenoxy)-Ethanone

Degré de pureté : 98+%

Masse moléculaire : 368.51g/mol

Ref: 54-OR1024304

IDF-11774

CAS : 1429054-28-3

IDF-11774

Degré de pureté : ≥98%

Masse moléculaire : 368.51g/mol

Ref: 54-BUP04921

IDF-11774

CAS : 1429054-28-3

IDF-11774 is a HIF-1 inhibitor.It reduces hif-1α HRE luciferase activity (IC50 = 3.65 μM).

Formule : C₂₃H₃₂N₂O₂

Degré de pureté : 98.05%

Couleur et forme : Solid

Masse moléculaire : 368.51

Ref: TM-T5537

IDF-11774

CAS : 1429054-28-3

IDF-11774 is an investigational drug that has shown promising results in preclinical studies. It inhibits the activity of the enzyme amp-activated protein kinase, which is a regulator of cell growth and survival. This inhibition leads to decreased tumor size and improved prognosis for patients with cancer. IDF-11774 has also been shown to inhibit cancer cells from spreading by preventing the synthesis of new proteins. The polymerase chain reaction (PCR) data collected from human osteosarcoma cells in culture demonstrated that IDF-11774 inhibited the production of DNA by inhibiting transcription. In addition, it also showed an increase in ATP levels and an uptake into tumor cells with a concomitant decrease in ATP levels in normal cells. These findings suggest that IDF-11774 may be useful for the treatment of urothelial carcinoma and chaperone-mediated autophagy (HCT116), while fetal bovine serum (FBS) or hepg2 cell lines were

Formule : C₂₃H₃₂N₂O₂

Degré de pureté : Min. 95%

Masse moléculaire : 368.51 g/mol

Ref: 3D-EHC05428